ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 210 filers reported holding ARGENX SE in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,799,128 | +18.4% | 3,659,515 | -6.1% | 0.26% | +24.5% |
| Q2 2023 | $1,518,942 | +6.6% | 3,897,419 | +1.9% | 0.21% | -0.5% |
| Q1 2023 | $1,424,740 | -5.0% | 3,823,983 | -3.4% | 0.21% | -11.6% |
| Q4 2022 | $1,500,048 | -99.9% | 3,959,686 | -6.6% | 0.24% | -1.6% |
| Q3 2022 | $1,496,470,000 | -38.1% | 4,238,689 | -33.5% | 0.24% | -19.7% |
| Q2 2022 | $2,416,237,000 | +23.7% | 6,377,316 | +3.0% | 0.30% | +54.8% |
| Q1 2022 | $1,953,182,000 | -0.5% | 6,194,481 | +10.5% | 0.20% | +11.3% |
| Q4 2021 | $1,962,309,000 | +16.7% | 5,603,556 | +0.7% | 0.18% | +12.0% |
| Q3 2021 | $1,681,306,000 | -0.0% | 5,567,238 | -0.3% | 0.16% | +1.3% |
| Q2 2021 | $1,681,942,000 | +5.4% | 5,586,549 | -3.6% | 0.16% | -2.5% |
| Q1 2021 | $1,595,469,000 | +10.2% | 5,793,488 | +17.7% | 0.16% | +7.4% |
| Q4 2020 | $1,447,505,000 | +7.4% | 4,921,980 | -4.1% | 0.15% | -4.5% |
| Q3 2020 | $1,347,414,000 | +13.7% | 5,132,613 | -2.5% | 0.16% | +4.7% |
| Q2 2020 | $1,185,246,000 | +131.9% | 5,262,379 | +35.6% | 0.15% | +84.0% |
| Q1 2020 | $511,135,000 | -21.0% | 3,880,174 | -3.7% | 0.08% | -3.6% |
| Q4 2019 | $646,811,000 | +47.3% | 4,029,476 | +4.6% | 0.08% | +35.5% |
| Q3 2019 | $438,964,000 | -18.6% | 3,851,912 | +1.2% | 0.06% | -18.4% |
| Q2 2019 | $538,937,000 | +20.0% | 3,806,592 | +5.8% | 0.08% | +15.2% |
| Q1 2019 | $449,018,000 | +123.0% | 3,596,744 | +71.6% | 0.07% | +94.1% |
| Q4 2018 | $201,391,000 | +37.2% | 2,096,292 | +8.3% | 0.03% | +61.9% |
| Q3 2018 | $146,746,000 | +3.6% | 1,934,941 | +13.1% | 0.02% | -4.5% |
| Q2 2018 | $141,706,000 | +9.4% | 1,710,183 | +6.2% | 0.02% | +4.8% |
| Q1 2018 | $129,501,000 | +158.5% | 1,609,910 | +102.9% | 0.02% | +162.5% |
| Q4 2017 | $50,100,000 | +495.2% | 793,481 | +111.5% | 0.01% | +700.0% |
| Q3 2017 | $8,418,000 | +3.7% | 375,137 | -2.0% | 0.00% | 0.0% |
| Q2 2017 | $8,119,000 | – | 382,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |